Composition
- Active ingredients
- MIPOMERSEN SODIUM 200MG/ML (200MG/ML)
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA203568.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Kynamro
- Active substance
- mipomersen sodium
- Route
- Subcutaneous
- Dosage form
- Solution
- Applicant
- Kastle Theraps LLC
- Status
- Discontinued
- FDA approval
- 29 Jan 2013
- Application
- NDA203568-001